Abstract
Proteogenomics represents a transformative intersection in nephrology, uniting genomics, transcriptomics, and proteomics to unravel the molecular intricacies of kidney diseases. This review encapsulates the methodological essence of proteogenomics and its profound implications in chronic kidney disease (CKD) research. We explore the proteogenomic pipeline, highlighting the integrated analysis of genomic, transcriptomic, and proteomic data and its pivotal role in enhancing our understanding of kidney pathologies. Through case studies, we showcase the application of proteogenomics in clear cell renal cell carcinoma (ccRCC) and Autosomal Recessive Polycystic Kidney Disease (ARPKD), emphasizing its potential in personalized treatment strategies and biomarker discovery. The review also addresses the challenges in proteogenomic analysis, including data integration complexities and bioinformatics limitations, and proposes solutions for advancing the field. Ultimately, this review underscores the prospective future of proteogenomics in nephrology, particularly in advancing personalized medicine and providing novel therapeutic insights.
Author supplied keywords
Cite
CITATION STYLE
Chavali, K., Coker, H., Youngblood, E., & Karaduta, O. (2024, May 1). Proteogenomics in Nephrology: A New Frontier in Nephrological Research. Current Issues in Molecular Biology. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/cimb46050279
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.